BeStock  
Markets › Compare › PTGX vs KRYS

PTGX vs KRYS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PTGX · Protagonist Therapeutics$121.40 ▼ 2.11%
KRYS · Krystal Biotech$308.89 ▼ 2.19%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

86111136161186Nov 24, '25May 26, '26Nov 20, '26
  • PTGX +38.4%
  • KRYS +43.7%

Head to head

MetricPTGXKRYS
Price$121.40$308.89
Change today▼ 2.11%▼ 2.19%
Market cap$7.92B$9.15B
Return, 3 months-21.5%-9.6%
Return, year to date+39.0%+25.3%
Return, 1 year+42.2%+45.7%
P/E (TTM)25.742.0
P/B7.36.4
P/E percentile vs own 5y78th68th
Dividend yield––
Revenue growth (YoY, latest qtr)+5,723.6%+30.2%
Net profit growth (YoY)+659.3%-20.5%
Gross margin99.6%94.3%
Operating margin58.6%48.4%
Net margin62.0%47.9%
Return on equity39.6%17.5%
Analyst target vs. price+48.3%+27.3%
Analyst buy share100%100%
RSI (14)3247
30-day volatility41.1%47.9%
Max drawdown, 1 year-23.5%-21.8%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • KRYS is the largest of the group by market value.
  • KRYS has returned the most over the past year.
  • PTGX carries the lowest trailing P/E.
  • PTGX is growing revenue fastest.
  • PTGX keeps the most profit per dollar of sales.
  • PTGX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top